SC Filed 2021-09-16 Event — SEC 0001387131-21-009488 →

GLAXOSMITHKLINE PLC → BICYCLE THERAPEUTICS plc BCYC

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 20/100

Passive Schedule 13G filer baseline
Held by 1 tracked 13F institutional manager
Elevated short days-to-cover (6.2 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

9 transactions

0 buys · 9 sales · 0 awards/exercises

Issuer Cluster

8 13D/G filings on this issuer

7 other filings besides this one

Filer Track Record

23 filings by this filer

22 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 6.23

3,453,064 shares short · +4.5% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $544K

Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-04-06	Perry Jennifer Scott	Chief Operating Officer	Sale	37	$5.05	$187
2026-04-06	Perry Jennifer Scott	Chief Operating Officer	Sale	333	$5.04	$2K
2026-04-06	Lee Kevin	CHIEF EXECUTIVE OFFICER	Sale	1,716	$5.05	$9K
2026-04-06	Hannay Michael Charles Ferguson	CHIEF PROD & SUPPLY CHAIN OFF	Sale	251	$5.05	$1K
2026-04-06	Thompson Travis Alvin	Chief Financial Officer	Sale	102	$5.05	$515
2026-04-02	Perry Jennifer Scott	Chief Operating Officer	Sale	1,038	$4.91	$5K
2026-04-02	Lee Kevin	CHIEF EXECUTIVE OFFICER	Sale	5,967	$4.91	$29K
2026-04-02	Hannay Michael Charles Ferguson	CHIEF PROD & SUPPLY CHAIN OFF	Sale	1,521	$4.91	$7K
2026-04-02	Thompson Travis Alvin	Chief Financial Officer	Sale	799	$4.91	$4K

Other 13D/G Filings on BICYCLE THERAPEUTICS plc

Filed	Form	Filer	Stake	Shares
2022-03-14	SC	TYBOURNE CAPITAL MANAGEMENT (HK) LTD	—	—	view →
2021-08-16	SC	SVLSF V, LLC	—	—	view →
2021-04-16	SC	GLAXOSMITHKLINE PLC	—	—	view →
2021-01-20	SC	Vertex Global HC Fund I Pte. Ltd.	—	—	view →
2020-12-07	SC	GLAXOSMITHKLINE PLC	—	—	view →
2020-11-12	SC	TYBOURNE CAPITAL MANAGEMENT (HK) LTD	—	—	view →
2020-07-20	SC	TYBOURNE CAPITAL MANAGEMENT (HK) LTD	—	—	view →

Other Filings by GLAXOSMITHKLINE PLC

Filed	Form	Issuer	Stake	Shares
2023-10-10	SC	Haleon plc HLNCF	—	—	view →
2022-11-14	SC	Spero Therapeutics, Inc. SPRO	—	—	view →
2022-09-20	SC	Theravance Biopharma, Inc. TBPH	—	—	view →
2022-02-10	SC	Theravance Biopharma, Inc. TBPH	—	—	view →
2021-09-16	SC	Spero Therapeutics, Inc. SPRO	—	—	view →
2021-05-25	SC	Innoviva, Inc. INVA	—	—	view →
2021-04-16	SC	BICYCLE THERAPEUTICS plc BCYC	—	—	view →
2021-04-08	SC	Pandion Therapeutics, Inc.	—	—	view →
2021-02-12	SC	Innoviva, Inc. INVA	—	—	view →
2020-12-07	SC	Spero Therapeutics, Inc. SPRO	—	—	view →
2020-12-07	SC	BICYCLE THERAPEUTICS plc BCYC	—	—	view →
2020-10-01	SC	Principia Biopharma Inc.	—	—	view →
2020-06-29	SC	Morphic Holding, Inc.	—	—	view →
2020-06-22	SC	Theravance Biopharma, Inc. TBPH	—	—	view →
2020-06-04	SC	Spero Therapeutics, Inc. SPRO	—	—	view →
2020-02-27	SC	Theravance Biopharma, Inc. TBPH	—	—	view →
2019-04-18	SC	Theravance Biopharma, Inc. TBPH	—	—	view →
2018-07-17	SC	Spero Therapeutics, Inc. SPRO	—	—	view →
2018-04-10	SC	Innoviva, Inc. INVA	—	—	view →
2018-02-13	SC	HTG MOLECULAR DIAGNOSTICS, INC	—	—	view →

Showing 20 of 22

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →